116 related articles for article (PubMed ID: 7902662)
1. Inhibition of topoisomerases in African trypanosomes.
Shapiro TA
Acta Trop; 1993 Sep; 54(3-4):251-60. PubMed ID: 7902662
[TBL] [Abstract][Full Text] [Related]
2. Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs.
Shapiro TA; Englund PT
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):950-4. PubMed ID: 2153980
[TBL] [Abstract][Full Text] [Related]
3. Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
Tang SC; Shapiro TA
Antimicrob Agents Chemother; 2010 Feb; 54(2):620-6. PubMed ID: 20008775
[TBL] [Abstract][Full Text] [Related]
4. Drugs affecting trypanosome topoisomerases.
Shapiro TA
Adv Pharmacol; 1994; 29B():187-200. PubMed ID: 8996608
[No Abstract] [Full Text] [Related]
5. Susceptibility of dyskinetoplastic Trypanosoma evansi and T. equiperdum to isometamidium chloride.
Kaminsky R; Schmid C; Lun ZR
Parasitol Res; 1997; 83(8):816-8. PubMed ID: 9342750
[TBL] [Abstract][Full Text] [Related]
6. Suramin: Effectiveness of analogues reveals structural features that are important for the potent trypanocidal activity of the drug.
Steverding D; Tinson RAJ; Piras M; Wren SP; Rushworth SA; Searcey M; Troeberg L
Exp Parasitol; 2024 May; 260():108744. PubMed ID: 38513971
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma brucei evansi: dyskinetoplasia and loss of infectivity after long-term in vitro cultivation.
Zweygarth E; Kaminsky R; Webster P
Acta Trop; 1990 Dec; 48(2):95-9. PubMed ID: 1980574
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
[TBL] [Abstract][Full Text] [Related]
9. A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin.
Morty RE; Troeberg L; Pike RN; Jones R; Nickel P; Lonsdale-Eccles JD; Coetzer TH
FEBS Lett; 1998 Aug; 433(3):251-6. PubMed ID: 9744805
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium.
Zhang ZQ; Giroud C; Baltz T
Acta Trop; 1991 Dec; 50(2):101-10. PubMed ID: 1685865
[TBL] [Abstract][Full Text] [Related]
11. The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure.
Cavalcanti DP; Fragoso SP; Goldenberg S; de Souza W; Motta MC
Parasitol Res; 2004 Dec; 94(6):439-48. PubMed ID: 15517387
[TBL] [Abstract][Full Text] [Related]
12. In vivo inhibition of trypanosome mitochondrial topoisomerase II: effects on kinetoplast DNA maxicircles.
Shapiro TA; Showalter AF
Mol Cell Biol; 1994 Sep; 14(9):5891-7. PubMed ID: 8065322
[TBL] [Abstract][Full Text] [Related]
13. Variation in resistance to isometamidium chloride and diminazene aceturate by clones derived from a stock of Trypanosoma congolense.
Peregrine AS; Knowles G; Ibitayo AI; Scott JR; Moloo SK; Murphy NB
Parasitology; 1991 Feb; 102 Pt 1():93-100. PubMed ID: 2038504
[TBL] [Abstract][Full Text] [Related]
14. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems.
Hannaert V
Planta Med; 2011 Apr; 77(6):586-97. PubMed ID: 20945274
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense.
Ebiloma GU; Ayuga TD; Balogun EO; Gil LA; Donachie A; Kaiser M; Herraiz T; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
Eur J Med Chem; 2018 Apr; 150():385-402. PubMed ID: 29544150
[TBL] [Abstract][Full Text] [Related]
16. The effect of verapamil alone and in combination with trypanocides on multidrug-resistant Trypanosoma brucei brucei.
Kaminsky R; Zweygarth E
Acta Trop; 1991 Aug; 49(3):215-25. PubMed ID: 1685302
[TBL] [Abstract][Full Text] [Related]
17. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
[TBL] [Abstract][Full Text] [Related]
18. The sensitivity to trypanocidal drugs of Trypanosoma vivax isolated in Kenya and Somalia.
Schönefeld A; Röttcher D; Moloo SK
Trop Med Parasitol; 1987 Sep; 38(3):177-80. PubMed ID: 3432953
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of existing drugs for animal trypanosomiasis.
Kinabo LD
Acta Trop; 1993 Sep; 54(3-4):169-83. PubMed ID: 7902656
[TBL] [Abstract][Full Text] [Related]
20. An ATP-Based Luciferase Viability Assay for Animal African Trypanosomes Using a 96-Well Plate.
Suganuma K; Molefe NI; Inoue N
Methods Mol Biol; 2017; 1601():89-95. PubMed ID: 28470520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
